{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:30:15Z","timestamp":1787020215798,"version":"build-2736575974"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T00:00:00Z","timestamp":1740700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-024-13313-3","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T03:59:56Z","timestamp":1740715196000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Two or three weeks of thyroid hormone withdrawal before initial 131I therapy for patients with differentiated thyroid carcinoma?"],"prefix":"10.1186","volume":"25","author":[{"given":"Yueqi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"issue":"4","key":"13313_CR1","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S2213-8587(21)00027-9","volume":"9","author":"A Miranda-Filho","year":"2021","unstructured":"Miranda-Filho A, Lortet-Tieulent J, Bray F, Cao B, Franceschi S, Vaccarella S, Dal Maso L. Thyroid cancer incidence trends by histology in 25 countries: a population-based study. Lancet Diabetes Endocrinol. 2021;9(4):225\u201334.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"13313_CR2","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/S2213-8587(22)00035-3","volume":"10","author":"M Pizzato","year":"2022","unstructured":"Pizzato M, Li M, Vignat J, Laversanne M, Singh D, La Vecchia C, Vaccarella S. The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020. Lancet Diabetes Endocrinol. 2022;10(4):264\u201372.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"13313_CR3","doi-asserted-by":"crossref","unstructured":"Teng Y, Xia C, Li H, Cao M, Yang F, Yan X, He S, Cao M, Zhang S, Li Q et al. Cancer statistics for young adults aged 20 to 49 years in China from 2000 to 2017: a population-based registry study. Sci China Life Sci 2023.","DOI":"10.1007\/s11427-023-2445-1"},{"issue":"1","key":"13313_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, et al. 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid Cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid Cancer. Thyroid. 2016;26(1):1\u2013133.","journal-title":"Thyroid"},{"issue":"1","key":"13313_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"key":"13313_CR6","doi-asserted-by":"crossref","unstructured":"Kaneda-Nakashima K, Shirakami Y, Watabe T, Ooe K, Yoshimura T, Toyoshima A, Wang Y, Haba H, Fukase K. Effect to Therapy of Sodium-Iodine Symporter expression by alpha-Ray Therapeutic Agent via Sodium\/Iodine Symporter. Int J Mol Sci 2022, 23(24).","DOI":"10.3390\/ijms232415509"},{"issue":"4","key":"13313_CR7","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1530\/eje.1.02257","volume":"155","author":"G Riesco-Eizaguirre","year":"2006","unstructured":"Riesco-Eizaguirre G, Santisteban P. A perspective view of sodium iodide symporter research and its clinical implications. Eur J Endocrinol. 2006;155(4):495\u2013512.","journal-title":"Eur J Endocrinol"},{"key":"13313_CR8","doi-asserted-by":"crossref","unstructured":"Coerts HI, de Keizer B, Marlowe RJ, Verburg FA. Recombinant or endogenous thyroid-stimulating hormone for radioactive iodine therapy in thyroid cancer: state of knowledge and current controversies. Eur J Endocrinol 2023, 188(2).","DOI":"10.1093\/ejendo\/lvad006"},{"issue":"1","key":"13313_CR9","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41598-023-27455-0","volume":"13","author":"YS An","year":"2023","unstructured":"An YS, Lee J, Kim HK, Lee SJ, Yoon JK. Effect of withdrawal of thyroid hormones versus administration of recombinant human thyroid-stimulating hormone on renal function in thyroid cancer patients. Sci Rep. 2023;13(1):206.","journal-title":"Sci Rep"},{"issue":"1","key":"13313_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1530\/eje.1.02310","volume":"156","author":"LH Duntas","year":"2007","unstructured":"Duntas LH, Biondi B. Short-term hypothyroidism after levothyroxine-withdrawal in patients with differentiated thyroid cancer: clinical and quality of life consequences. Eur J Endocrinol. 2007;156(1):13\u20139.","journal-title":"Eur J Endocrinol"},{"key":"13313_CR11","doi-asserted-by":"publisher","first-page":"1114344","DOI":"10.3389\/fendo.2023.1114344","volume":"14","author":"J Yao","year":"2023","unstructured":"Yao J, Zhao J, Liu J, Jiang S, Guo S, Xu L, Zhang X, Sheng Q, Wang K, Liao L, et al. The relationships between thyroid functions of short-term rapid hypothyroidism and blood lipid levels in post-thyroidectomy patients of differentiated thyroid cancer. Front Endocrinol (Lausanne). 2023;14:1114344.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"26","key":"13313_CR12","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1200\/JCO.2015.61.6722","volume":"33","author":"I Borget","year":"2015","unstructured":"Borget I, Bonastre J, Catargi B, D\u00e9andr\u00e9is D, Zerdoud S, Rusu D, Bardet S, Leenhardt L, Bastie D, Schvartz C, et al. Quality of life and cost-effectiveness Assessment of Radioiodine ablation strategies in patients with thyroid Cancer: results from the Randomized Phase III ESTIMABL Trial. J Clin Oncol. 2015;33(26):2885\u201392.","journal-title":"J Clin Oncol"},{"issue":"7","key":"13313_CR13","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1007\/s00259-018-3955-x","volume":"45","author":"A Piccardo","year":"2018","unstructured":"Piccardo A, Puntoni M, Ferrarazzo G, Foppiani L, Bottoni G, Altrinetti V, Treglia G, Naseri M, Dib B, Cabria M, et al. Could short thyroid hormone withdrawal be an effective strategy for radioiodine remnant ablation in differentiated thyroid cancer patients? Eur J Nucl Med Mol Imaging. 2018;45(7):1218\u201323.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"13313_CR14","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1007\/s00259-015-3223-2","volume":"43","author":"A Vrachimis","year":"2016","unstructured":"Vrachimis A, Riemann B, M\u00e4der U, Reiners C, Verburg FA. Endogenous TSH levels at the time of (131)I ablation do not influence ablation success, recurrence-free survival or differentiated thyroid cancer-related mortality. Eur J Nucl Med Mol Imaging. 2016;43(2):224\u201331.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"599","key":"13313_CR15","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1259\/0007-1285-50-599-799","volume":"50","author":"CJ Edmonds","year":"1977","unstructured":"Edmonds CJ, Hayes S, Kermode JC, Thompson BD. Measurement of serum TSH and thyroid hormones in the management of treatment of thyroid carcinoma with radioiodine. Br J Radiol. 1977;50(599):799\u2013807.","journal-title":"Br J Radiol"},{"issue":"6","key":"13313_CR16","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1097\/RLU.0000000000001167","volume":"41","author":"T Zhao","year":"2016","unstructured":"Zhao T, Liang J, Guo Z, Li T, Lin Y. In patients with low- to intermediate-risk thyroid Cancer, a preablative thyrotropin level of 30 \u00b5IU\/mL is not adequate to Achieve Better response to 131I therapy. Clin Nucl Med. 2016;41(6):454\u20138.","journal-title":"Clin Nucl Med"},{"issue":"3","key":"13313_CR17","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/j.1365-2265.2007.03068.x","volume":"68","author":"G Targher","year":"2008","unstructured":"Targher G, Montagnana M, Salvagno G, Moghetti P, Zoppini G, Muggeo M, Lippi G. Association between serum TSH, free T4 and serum liver enzyme activities in a large cohort of unselected outpatients. Clin Endocrinol (Oxf). 2008;68(3):481\u20134.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"13313_CR18","doi-asserted-by":"publisher","first-page":"e045562","DOI":"10.1136\/bmjopen-2020-045562","volume":"12","author":"Y Ji","year":"2022","unstructured":"Ji Y, Zheng W, Meng Z, Wu C, Tan J, Wang R. Retrospective study of the influence of hypothyroidism on liver function before radioiodine therapy in China: a comparison analysis based on patients with differentiated thyroid cancer. BMJ Open. 2022;12(1):e045562.","journal-title":"BMJ Open"},{"issue":"5","key":"13313_CR19","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrendo.2018.10","volume":"14","author":"RA Sinha","year":"2018","unstructured":"Sinha RA, Singh BK, Yen PM. Direct effects of thyroid hormones on hepatic lipid metabolism. Nat Rev Endocrinol. 2018;14(5):259\u201369.","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"13313_CR20","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1089\/thy.2018.0190","volume":"29","author":"GA Sigal","year":"2019","unstructured":"Sigal GA, Tavoni TM, Silva BMO, Kalil Filho R, Brand\u00e3o LG, Maranh\u00e3o RC. Effects of short-term hypothyroidism on the lipid transfer to high-density lipoprotein and other parameters related to Lipoprotein metabolism in patients submitted to thyroidectomy for thyroid Cancer. Thyroid. 2019;29(1):53\u20138.","journal-title":"Thyroid"},{"issue":"2","key":"13313_CR21","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1089\/thy.2017.0330","volume":"28","author":"CM Beukhof","year":"2018","unstructured":"Beukhof CM, Massolt ET, Visser TJ, Korevaar TIM, Medici M, de Herder WW, van Roeters JE, Mulder MT, de Rijke YB, Reiners C, et al. Effects of Thyrotropin on Peripheral thyroid hormone metabolism and serum lipids. Thyroid. 2018;28(2):168\u201374.","journal-title":"Thyroid"},{"issue":"1","key":"13313_CR22","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s12020-023-03361-3","volume":"82","author":"MM Allam","year":"2023","unstructured":"Allam MM, El-Zawawy HT, El-Zawawy TH. Renal function changes in patients with subclinical hyperthyroidism: a novel postulated mechanism. Endocrine. 2023;82(1):78\u201386.","journal-title":"Endocrine"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-13313-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-024-13313-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-024-13313-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T04:00:01Z","timestamp":1740715201000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-024-13313-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,28]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13313"],"URL":"https:\/\/doi.org\/10.1186\/s12885-024-13313-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,28]]},"assertion":[{"value":"8 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of West China Hospital of Sichuan University (#20232091). The informed consents of all patients were waived owing to the retrospective nature of this study (#20232091). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not application.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"370"}}